Cowden syndrome overview

Revision as of 12:46, 26 March 2019 by Gunnam (talk | contribs) (→‎Overview)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Cowden syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cowden Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cowden syndrome overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cowden syndrome overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cowden syndrome overview

CDC on Cowden syndrome overview

Cowden syndrome overview in the news

Blogs on Cowden syndrome overview

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cowden syndrome overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Overview

Cowden syndrome is an inherited disorder which follows autosomal dominant pattern. Cowden syndrome is characterized by multiple tumor-like growths called hamartomas. Most of the patients with cowden syndrome condition presents with hamartomas. These small, noncancerous growths are most commonly found on the skin and mucous membranes, but can also occur in the gastrointestinal tract and other parts of the body. People with Cowden syndrome are more prone to risk of developing several types of cancer, including cancers of the breast, thyroid, and uterus. Women with Cowden syndrome have as much as a 25-50% lifetime risk of developing breast cancer.

Historical Perspective

Cowden syndrome/ Cowden's disease/ multiple hamartoma syndrome follows autosomal dominant fashion of inheritance. Cowden syndrome was first described in 1940 by Salem and Steck.

Classification

There is no established system for the classification of cowden syndrome.

Pathophysiology

It is thought that cowden syndrome is the result caused by phosphatase and tensin homolog (PTEN) gene mutations. Cowden syndrome follows autosomal dominant pattern of inheritance.

Causes

The most common cause of cowden syndrome is PTEN gene mutations.

Differentiating cowden syndrome from Other Diseases

Cowden syndrome must be differentiated from the following Familial Adenomatous Polyposis, Peutz–Jeghers syndrome, Carney Syndrome and Hereditary Non–Polyposis Colon Cancer.

Epidemiology and Demographics

The incidence of rare disease cowden syndrome is approximately 1 in 250,000 individuals. The prevalence of cowden syndrome is unknown. The incidence of cowden syndrome increases with age. Cowden syndrome affects men and women equally.

Risk Factors

There are no established risk factors for cowden syndrome.

Screening

According to the National Comprehensive Cancer Network (NCCN) Guidelines, screening for cowden syndrome patients is recommended for women who are at risk for breast cancer, uterine cancer and colon cancer.

Natural History, Complications, and Prognosis

Cowden syndrome follows an autosomal dominant pattern of inheritance. If left untreated, patients with cowden syndrome may prone to develop manu cancers.Common complications of cowden syndrome include breast, colon cancer and endometrial cancer. Prognosis is generally ranges from excellent to poor.

Diagnosis

Diagnostic Study of Choice

Biopsy is the gold standard and definitive test for diagnosis of cowden syndrome. The diagnostic criteria of cowden syndrome is based on the Cowden syndrome/PHTS criteria which include Pilarski et al diagnostic criteria.

History and Symptoms

The hallmark of cowden syndrome is Trichilemmomas. A positive history of PTEN gene mutation is suggestive of cowden syndrome. The most common symptoms of cowden syndrome includetrichilemmomas, oral papillomas and acral keratoses is suggestive of cowden syndrome.

Physical Examination

Common physical examination findings of cowden syndrome include trichilemmomas, acral keratoses, and facial papules. The presence of trichilemmomas on physical examination is highly suggestive of cowden syndrome.

Laboratory Findings

Laboratory findings consistent with the diagnosis of cowden syndrome include skin biopsy, chemistry panels, urinalysis, thyroid function tests and cbc count.

Electrocardiogram

There are no ECG findings associated with Cowden syndrome.

X-ray

There are no x-ray findings associated with cowden syndrome.

Echocardiography and Ultrasound

There are ultrasound findings associated with cowden syndrome. Ultrasound may be helpful in the diagnosis of complications of cowden syndrome, which include testicular swelling, hydrocele, and hyperechoic masses of the testes.

CT scan

Head and neck CT scan may be helpful in the diagnosis of cowden syndrome. Findings on CT scan suggestive of cowden syndrome include enlarged thyroid lobes and calcifications.

MRI

Spine MRI may be helpful in the diagnosis of cowden syndrome. Findings on MRI suggestive of cowden syndrome include thoracolumbar scoliosis and disc disease.

Other Imaging Findings

There are no other imaging findings associated with cowden syndrome.

Other Diagnostic Studies

There are no other diagnostic studies associated with cowden syndrome.

Treatment

Medical Therapy

Due to different phenotypes cowden syndrome is likely to be an underdiagnosed condition. Pharmacologic medical therapy is recommended among patients with cutaneous manifestations in cowden syndrome.

Surgery

Surgery is not the first-line treatment option for patients with cowden syndrome. Surgery is usually reserved for patients with gastrointestinal polyps, Dysplastic Gangliocytoma and facial papules.

Primary Prevention

There are no established measures for the primary prevention of cowden syndrome.

Secondary Prevention

There are no established measures for the secondary prevention of cowden syndrome.

References


Template:WikiDoc Sources